Secretogranin II: Molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin, Progress in Neurobiology, vol.46, issue.1, pp.49-70, 1995. ,
DOI : 10.1016/0301-0082(94)00060-U
The chromogranins A and B: The first 25 years and future perspectives, Neuroscience, vol.49, issue.3, pp.497-528, 1992. ,
DOI : 10.1016/0306-4522(92)90222-N
The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects, Biological Reviews, vol.266, issue.4, pp.769-794, 2004. ,
DOI : 10.1016/S0167-4838(97)00137-4
Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma, Regulatory Peptides, vol.165, issue.1, pp.21-29, 2010. ,
DOI : 10.1016/j.regpep.2010.06.003
New insights into granin-derived peptides: evolution and endocrine roles, General and Comparative Endocrinology, vol.164, issue.2-3, pp.161-174, 2009. ,
DOI : 10.1016/j.ygcen.2009.01.011
The granin protein family: Markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors, Journal of Endocrinological Investigation, vol.85, issue.3, pp.207-225, 1994. ,
DOI : 10.1172/JCI114604
The Chromogranin???Secretogranin Family, New England Journal of Medicine, vol.348, issue.12, pp.1134-1149, 2003. ,
DOI : 10.1056/NEJMra021405
The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours, Anticancer Res, vol.19, pp.3415-3427, 1999. ,
Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms, New England Journal of Medicine, vol.314, issue.18, pp.1145-1151, 1986. ,
DOI : 10.1056/NEJM198605013141803
Impact of chromogranin A measurement in the work-up of neuroendocrine tumors, Annals of Oncology, vol.12, issue.2suppl, pp.79-82, 2001. ,
DOI : 10.1023/A:1012494309486
Chromogranin A and the ?? -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma, British Journal of Cancer, vol.84, issue.6, pp.808-812, 2001. ,
DOI : 10.1054/bjoc.2000.1677
Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids, The Journal of Pathology, vol.381, issue.3, pp.321-325, 1999. ,
DOI : 10.7326/0003-4819-120-4-199402150-00008
Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value., Journal of Clinical Investigation, vol.83, issue.6, pp.1834-1842, 1989. ,
DOI : 10.1172/JCI114089
Comparison of Plasma Pancreastatin and GAWK Concentrations, Presumed Processing Products of Chromogranin A and B, in Plasma of Patients with Pancreatic Islet Cell Tumors, Hormone and Metabolic Research, vol.25, issue.11, pp.593-595, 1993. ,
DOI : 10.1055/s-2007-1002184
The secretory granule peptides 7B2 and CCB are sensitive biochemical markers of neuro-endocrine bronchial tumours in man, Clinical Endocrinology, vol.43, issue.4, pp.319-325, 1991. ,
DOI : 10.1007/BF02890062
Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas, Neuroscience Letters, vol.253, issue.1, pp.17-20, 1998. ,
DOI : 10.1016/S0304-3940(98)00588-6
Levels and Molecular Properties of Secretoneurin-Immunoreactivity in the Serum and Urine of Control and Neuroendocrine Tumor Patients, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.1, pp.355-360, 2000. ,
DOI : 10.1210/jc.85.1.355
ELEVATED LEVELS OF SERUM SECRETONEURIN IN PATIENTS WITH THERAPY RESISTANT CARCINOMA OF THE PROSTATE, The Journal of Urology, vol.163, issue.4, pp.1161-1164, 2000. ,
DOI : 10.1016/S0022-5347(05)67714-2
Germ-Line Mutations in Nonsyndromic Pheochromocytoma, New England Journal of Medicine, vol.346, issue.19, pp.1459-1466, 2002. ,
DOI : 10.1056/NEJMoa020152
Genetic Testing for Pheochromocytoma, Current Hypertension Reports, vol.3, issue.Suppl 5, pp.456-464, 2010. ,
DOI : 10.1093/qjmed/77.2.1151
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061287/pdf
Genetic markers for the diagnosis and prognosis of pheochromocytoma, Expert Review of Endocrinology & Metabolism, vol.103, issue.1, pp.45-52, 2009. ,
DOI : 10.1007/BF01938677
Genetics of pheochromocytoma and paraganglioma syndromes, Current Opinion in Endocrinology & Diabetes and Obesity, vol.20, issue.3, pp.186-191, 2013. ,
DOI : 10.1097/MED.0b013e32835fcc45
Genetic Testing in Pheochromocytoma or Functional Paraganglioma, Journal of Clinical Oncology, vol.23, issue.34, pp.8812-8818, 2005. ,
DOI : 10.1200/JCO.2005.03.1484
Malignant pheochromocytomas and paragangliomas ??? The importance of a multidisciplinary approach, Cancer Treatment Reviews, vol.37, issue.2, pp.111-119, 2011. ,
DOI : 10.1016/j.ctrv.2010.07.002
Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides, FEBS Letters, vol.66, issue.3, pp.295-299, 1996. ,
DOI : 10.1046/j.1471-4159.1996.66062248.x
Identification of a novel secretogranin II-derived peptide (SgII 187?252 ) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide, J Clin Endocrinol Metab, vol.83, pp.2944-2951, 1998. ,
Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells, Regulatory Peptides, vol.137, issue.1-2, pp.79-88, 2006. ,
DOI : 10.1016/j.regpep.2006.04.023
Biochemical Characterization and Immunocytochemical Localization of EM66, a Novel Peptide Derived from Secretogranin II, in the Rat Pituitary and Adrenal Glands, Journal of Histochemistry & Cytochemistry, vol.60, issue.8, pp.1083-1095, 2003. ,
DOI : 10.1074/jbc.275.17.12553
Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma, International Journal of Cancer, vol.24, issue.8, pp.2003-2012, 2006. ,
DOI : 10.1001/jama.288.3.314
Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66, Journal of Molecular Endocrinology, vol.48, issue.2, pp.115-127, 2012. ,
DOI : 10.1530/JME-11-0077
Malignant Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.6, pp.2579-2585, 2003. ,
DOI : 10.1210/jc.2002-021748
Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands, Cell and Tissue Research, vol.310, issue.2, pp.223-236, 2002. ,
DOI : 10.1007/s00441-002-0625-9
Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors, Endocrine Related Cancer, vol.16, issue.1, pp.281-290, 2009. ,
DOI : 10.1677/ERC-08-0190
Isolation of peptides arising from the specific posttranslational processing of chromogranin A and chromogranin B from human pheochromocytoma tissue, Peptides, vol.13, issue.4, pp.639-644, 1992. ,
DOI : 10.1016/0196-9781(92)90167-2
Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour, FEBS Letters, vol.288, issue.3, pp.319-321, 1992. ,
DOI : 10.1016/0014-5793(88)80606-9
Occurrence of WE-14 and chromogranin A-derived peptides in tissues of the human and bovine gastro-entero-pancreatic system and in human neuroendocrine neoplasia, Journal of Endocrinology, vol.151, issue.3, pp.409-420, 1996. ,
DOI : 10.1677/joe.0.1510409
Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid, Journal of Endocrinology, vol.152, issue.2, pp.275-281, 1997. ,
DOI : 10.1677/joe.0.1520275
Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas, Pituitary, vol.3, issue.2, pp.67-75, 2000. ,
DOI : 10.1023/A:1009949623054
An analysis of the biochemical diagnosis of 66 pheochromocytomas, European Journal of Endocrinology, vol.156, issue.5, pp.569-575, 2007. ,
DOI : 10.1530/EJE-06-0640
A comparison between three commercial kits for chromogranin A measurements, Journal of Endocrinology, vol.177, issue.2, pp.337-341, 2003. ,
DOI : 10.1677/joe.0.1770337
Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy, European Journal of Clinical Investigation, vol.104, issue.9, pp.802-811, 2001. ,
DOI : 10.1210/jc.84.8.2712
Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours, Journal of Endocrinology, vol.144, issue.1, pp.49-59, 1995. ,
DOI : 10.1677/joe.0.1440049
Basal Chromogranin a and Gastrin Concentrations in Circulation Correlate to Endocrine Cell Proliferation in Type-A Gastritis, Scandinavian Journal of Gastroenterology, vol.110, issue.3, pp.198-202, 1997. ,
DOI : 10.3109/00365517209081114
Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits, World Journal of Gastroenterology, vol.11, issue.13, pp.1987-1990, 2005. ,
DOI : 10.1007/0-306-46837-9_28
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones, J Clin Endocrinol Metab, vol.82, pp.2622-2628, 1997. ,
Evaluation of multiplex immunoassays, used for determination of adiponectin, resistin, leptin, and ghrelin from human blood samples, in comparison to ELISA assays, Scandinavian Journal of Clinical and Laboratory Investigation, vol.150, issue.3, pp.221-226, 2011. ,
DOI : 10.1210/en.2009-0697
Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer, Oncology Reports, vol.28, issue.2, pp.585-591, 2012. ,
DOI : 10.3892/or.2012.1829
Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions, Clinical Endocrinology, vol.411, issue.4, 2013. ,
DOI : 10.1016/j.cca.2010.01.012
Imaging vs Biochemical Testing for Pheochromocytoma, JAMA: The Journal of the American Medical Association, vol.288, issue.3, pp.314-315, 2002. ,
DOI : 10.1001/jama.288.3.314
The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2859-2866, 2004. ,
DOI : 10.1210/jc.2003-031127